Prednisone Not Yet Recruiting Phase 2 Trials for Prostate Cancer / Metastatic Hormone Refractory Prostate Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03833921Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
NCT03934840Phase 2 of Carbo, Taxel and Abi in Metastatic Castration Prostate Cancer